Posts Tagged ‘Diabetes’

Lung Cancer Foundation Charity 5K Run to Show Support for Boston

Posted: Apr 17, 2013 | Posted by Kassy Perry | No Comments

26-second moment of silence will be observed, runners encouraged to wear blue and yellow

DALLAS, Texas – The 3rd Annual Your Next Step is the Cure 5K walk/run at Reverchon Park on Saturday will honor the victims and heroes of Monday’s Boston Marathon bombing by starting with a 26-second moment of silence – one second for every mile of the marathon.

The Bonnie J. Addario Lung Cancer Foundation (LCF), who is hosting the event to raise funds for lung cancer awareness and research, is also encouraging runners to wear blue and yellow, the colors of the Boston Marathon.

“We are banding together with the running community all over the country this weekend to honor the victims and heroes of the Boston Marathon bombing,” said Bonnie J. Addario, director and founder of the LCF. “Raising awareness for lung cancer is still the goal of our run, but in light of the events this week we felt compelled to show our support.”

California Biopharmaceutical Companies Are Developing Over Two-Fifths of Breakthrough Biotechnology Medicines

Posted: Oct 13, 2011 | Posted by Kassy Perry | No Comments

WASHINGTON — (BUSINESS WIRE) — More than 400 of the record 901 biotechnology medicines in development today are being created by biopharmaceutical companies with major operations in California, a new report shows.

Companies with headquarters there account for 201 of the new-generation drugs.

The report, compiled by the Pharmaceutical Research and Manufacturers of America (PhRMA), finds that California’s biopharmaceutical companies have embraced a variety of new techniques as they develop 92 biotechnology-derived vaccines to both prevent and treat disease, 193 monoclonal antibody treatments, 33 recombinant proteins and other medicines made from cells and genes.

California Companies Target Heart Disease, Cancer With More Than 240 Medicines in Development

Posted: May 23, 2011 | Posted by Kassy Perry | No Comments

WASHINGTON–(BUSINESS WIRE)–At a time when cancer and heart disease are the nation’s and the world’s top killers, biopharmaceutical research companies headquartered in California are developing 243 of the 1,186 medicines in development for those dreaded diseases.

The California companies are developing 188 of 887 drugs for more than 20 types of cancer and 55 of 299 medicines for heart disease and stroke.

The cancer statistics are contained in a new report “Medicines in Development for Cancer” published by the Pharmaceutical Research and Manufacturers of America (PhRMA), while the data on heart disease and stroke are from a PhRMA report from early this year.

The cancer report and “Medicines in Development for Heart Disease and Stroke” can be found on the PhRMA website,

Case Study: The Faces of Diabetes

Posted: Jan 18, 2011 | Posted by Kassy Perry | No Comments

Messenger Makes the Message

The best message can be reduced to gibberish without the right messenger; and only the most credible messenger can break through cultural barriers and stimulate social change in health care. Despite widespread public health efforts working to stem the rising tide of diabetes in the United States, Latinos and African Americans continue to be disproportionately affected. Through engagement of credible and relatable messengers PCG built strategic partnerships and developed a meaningful health resource, positioning the Amylin-Lilly Alliance as a committed partner with more than marketing in mind. “The Faces of Diabetes: Diabetes, Your Family, and You,” featured local families and provided medical, social and pictorial perspectives based on the real experiences of Latinos and African Americans affected by diabetes in local communities.

By working with state and local chapters of the American Diabetes Association as well as community health centers, ethnic organizations and physician to create and distribute this non-promotional publication in English and Spanish, PCG demonstrated the Alliance’s recognition of and respect for cultural values and customs while providing a reliable source of information to reduce morbidity and mortality in underserved populations.